Evogene Ltd., a computational biology company, is leading the charge in product discovery and development across various life-science based industries. The company's Computational Predictive Biology (CPB) platform, utilizing big data and artificial intelligence, is designed to guide the development of life-science products based on microbes, small molecules, and genetic elements. Evogene operates in three segments: Agriculture, Industrial Applications, and Human Health. Under the Agriculture segment, the company has developed seed traits, ag-chemical products, and ag-biological products focused on crops such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment has developed enhanced castor bean seeds for use in other industrial applications. The Human Health segment is focused on discovering and developing human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. Additionally, Evogene provides medical cannabis products. The company has strategic collaborations and licensing agreements with some of the biggest names in the agricultural industry, including BASF SE, Corteva, and Bayer. Through its subsidiary, Canonic Ltd., Evogene also has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene is headquartered in Rehovot, Israel, and operates in the United States, Israel, Brazil, and internationally. The company was founded in 1999 and has since continued to make significant strides in transforming the life-science industries.
EverGen Infrastructure's ticker is EVGN
The company's shares trade on the NASDAQ stock exchange
They are based in Rehovot, Israel
There are 51-200 employees working at EverGen Infrastructure
It is evergeninfra.com
EverGen Infrastructure is in the Healthcare sector
EverGen Infrastructure is in the Biotechnology industry
The following five companies are EverGen Infrastructure's industry peers: